Aaron Cowen’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding CANO.WS
LP
ICM
UFM
AWG
ZA
GL
DCM
Aaron Cowen's CANO.WS Position: Q3 2022 in Review
Aaron Cowen sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q3 2022, closing a stake of 378,569 shares — an estimated $257K sold.
Aaron Cowen first reported a position in CANO.WS in Q2 2021 and held it in 5 quarters. The position peaked at $2.79M in Q3 2021. 30 funds tracked by Wall St. Rank hold CANO.WS as of Q3 2022.
- Aaron Cowen reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q3 2022 after selling out during the quarter.
- Aaron Cowen sold 378,569 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q3 2022, an estimated $257K.
- Aaron Cowen first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q2 2021 and held it in 5 quarters.
- Aaron Cowen's Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $2.79M in Q3 2021.
- 30 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q3 2022.
Based on Suvretta Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.